1 ML methylprednisolone acetate 40 MG/ML Injection
- RxCUI
- 1743779
- RxNorm name
- 1 ML methylprednisolone acetate 40 MG/ML Injection
- Display name
- methylPREDNISolone (Injectable)
- Full name
- 1 ML methylprednisolone acetate 40 MG/ML Injection
- Term type
- SCD
- Status
- Active
- Strength
- 40 mg/ml
- Dose form
- Injection 1 ml
- Route
- Injectable
- Updated
- 2026-10-22 07:01:15
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042016
- Active start
- 042016
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| methylprednisolone acetate | 40 MG / 1 ML | methylprednisolone | methylprednisolone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| methylprednisolone | 6902 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | 1 ML methylPREDNISolone acetate 40 MG/ML Injection | 1 | NAMES |
| RxNorm Name | 1 ML methylprednisolone acetate 40 MG/ML Injection | 1 | NAMES |
| RxNorm Synonym | methylprednisolone acetate 40 MG per 1 ML Injection | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 11 linked values
| 11 | CODES |
| RxCUI | 1743779 | 1 | CODES |
| MMSL_CODE | MTH_RXN_BD2312 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 50090-5894-0 | 50090-5894 | Methylprednisolone acetate Methylprednisolone acetate | A-S Medication Solutions | ANDA210043 |
| 60219-1573-1 | 60219-1573 | Methylprednisolone acetate Methylprednisolone acetate | Amneal Pharmaceuticals NY LLC | ANDA210043 |
| 60219-1573-5 | 60219-1573 | Methylprednisolone acetate Methylprednisolone acetate | Amneal Pharmaceuticals NY LLC | ANDA210043 |
| 65145-192-25 | 65145-192 | Methylprednisolone Acetate Methylprednisolone Acetate | Caplin Steriles Limited | ANDA220556 |
| 70121-1573-1 | 70121-1573 | Methylprednisolone acetate Methylprednisolone acetate | Amneal Pharmaceuticals LLC | ANDA210043 |
| 70121-1573-5 | 70121-1573 | Methylprednisolone acetate Methylprednisolone acetate | Amneal Pharmaceuticals LLC | ANDA210043 |
| 85766-031-01 | 85766-031 | Methylprednisolone acetate Methylprednisolone acetate | Sportpharm LLC | ANDA210043 |
| 85766-031-25 | 85766-031 | Methylprednisolone acetate Methylprednisolone acetate | Sportpharm LLC | ANDA210043 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA210043 | 50090-5894 | Methylprednisolone acetate Methylprednisolone acetate | ANDA | A-S Medication Solutions |
| ANDA220556 | 65145-192 | Methylprednisolone Acetate Methylprednisolone Acetate | ANDA | Caplin Steriles Limited |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylprednisolone Acetate | METHYLPREDNISOLONE ACETATE | Caplin Steriles Limited | 23f98766-7571-49cb-8c1a-58fabba53965 | 2026-02-06 | Warnings, Adverse reactions | 65145-192-25 65145-192 65145019201 65145019225 1743779 |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Sportpharm LLC | 62f4339a-a971-414d-b407-ef030fe4f989 | 2026-02-06 | Warnings, Adverse reactions | 85766-031-25 85766-031-01 85766-031 85766003125 85766003101 1743779 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 9a7b3837-e038-48bf-97e9-78ad463760dc | 2026-01-21 | Warnings, Adverse reactions | 1743779 |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals NY LLC | 8ea42650-21cd-49e4-92c8-48f2eeaf95bc | 2026-01-19 | Warnings, Adverse reactions | 60219-1573-5 60219-1573-1 60219-1573 60219157301 60219157305 1743779 |
| Dyural 40 Kit | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, SODIUM CHLORIDE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | 151ae26c-bd4e-4582-b67a-7b5baf466953 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 70121-1573-5 70121157305 1743779 |
| Dyural L Kit | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | 4879f990-e879-47e1-99bc-b4bfcb32bcff | 2026-01-08 | Warnings, Adverse reactions | 70121-1573-1 70121157301 1743779 |
| Multi-Specialty Kit | DEPO-MEDROL, LIDOCAINE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | 5f2768d1-90c4-4d73-902d-fc7a947da7a5 | 2026-01-08 | Warnings, Adverse reactions | 70121-1573-5 70121157305 1743779 |
| Dyural LM Kit | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | cdd72141-10b6-48c6-85be-5b1294c8539c | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 70121-1573-5 70121157305 1743779 |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals LLC | d944240d-2c19-46ba-ad4f-3fbee7b8629c | 2025-12-15 | Warnings, Adverse reactions | 70121-1573-5 70121-1573-1 70121-1573 70121157301 70121157305 1743779 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | bf1b104d-85cb-414d-a366-78068c82c883 | 2025-12-01 | Warnings, Adverse reactions | 1743779 |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | 1084208f-3b86-4aef-8247-5b6ed6cd50c7 | 2025-11-07 | Warnings, Adverse reactions | 50090-5894-0 50090-5894 50090589400 1743779 |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | cb457bef-8823-4f3c-987b-eb0922494c46 | 2025-11-06 | Warnings, Adverse reactions | 1743779 |
| Multi-Specialty Kit | DEPO-MEDROL, LIDOCAINE, ISOPROPYL ALCOHOL | Advanced Rx Pharmacy of Tennessee, LLC | fb85b480-d0cd-2539-e053-6294a90a5083 | 2024-12-31 | Warnings, Adverse reactions | 70121-1573-5 70121157305 1743779 |
| Dyural 40 Kit | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, SODIUM CHLORIDE, ISOPROPYL ALCOHOL | Advanced Rx Pharmacy of Tennessee, LLC | 01ca16de-ab2e-4e19-e063-6394a90a0510 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 70121-1573-5 70121157305 1743779 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9a7b3837-e038-48bf-97e9-78ad463760dc | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 27 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20260121 |
| cb457bef-8823-4f3c-987b-eb0922494c46 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 20 | DEPO-MEDROL | 20251106 |
| bf1b104d-85cb-414d-a366-78068c82c883 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 17 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20251201 |
| d944240d-2c19-46ba-ad4f-3fbee7b8629c | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 16 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | 20251215 |
| cdd72141-10b6-48c6-85be-5b1294c8539c | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 12 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | 20260108 |
| 151ae26c-bd4e-4582-b67a-7b5baf466953 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 11 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION.BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | 20260108 |
| 4879f990-e879-47e1-99bc-b4bfcb32bcff | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 11 | Dyural L Kit | 20260108 |
| 5f2768d1-90c4-4d73-902d-fc7a947da7a5 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 11 | Multi-Specialty Kit | 20260108 |
| 1084208f-3b86-4aef-8247-5b6ed6cd50c7 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 7 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | 20251107 |
| 8ea42650-21cd-49e4-92c8-48f2eeaf95bc | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 5 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | 20260119 |
| 62f4339a-a971-414d-b407-ef030fe4f989 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 2 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | 20260206 |
| 01ca16de-ab2e-4e19-e063-6394a90a0510 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 2 | Dyural 40 Kit These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION.BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | 20241231 |
| fb85b480-d0cd-2539-e053-6294a90a5083 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 2 | Multi-Specialty Kit | 20241231 |
| 9a3f33a6-a651-4ebc-e053-2995a90aadd7 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 2 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP 40mg/mL, 1mL VIAL | 20200222 |
| 23f98766-7571-49cb-8c1a-58fabba53965 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 1 | Methylprednisolone Acetate Injectable Suspension, USP Single-Dose Vial Not For Intravenous Use | 20260206 |
| 92cb6339-75ab-48eb-b304-19db59695883 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 1 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20140205 |
| 369e030c-1ea4-4104-885c-a60d6cedf072 | methylPREDNISolone acetate 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [SCD] · methylprednisolone acetate 40 MG per 1 ML Injection [SY] | 3 | 1 | MethylPREDNISolone ACETATE Injectable Suspension USP | 20120829 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 62f4339a-a971-414d-b407-ef030fe4f989 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | Sportpharm LLC | 20260206 |
| 23f98766-7571-49cb-8c1a-58fabba53965 | Methylprednisolone Acetate Injectable Suspension, USP Single-Dose Vial Not For Intravenous Use | Caplin Steriles Limited | 20260206 |
| 8ea42650-21cd-49e4-92c8-48f2eeaf95bc | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | Amneal Pharmaceuticals NY LLC | 20260119 |
| cdd72141-10b6-48c6-85be-5b1294c8539c | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | Asclemed USA, Inc. | 20260108 |
| 151ae26c-bd4e-4582-b67a-7b5baf466953 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION.BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | Asclemed USA, Inc. | 20260108 |
| 5f2768d1-90c4-4d73-902d-fc7a947da7a5 | Multi-Specialty Kit | Asclemed USA, Inc. | 20260108 |
| 4879f990-e879-47e1-99bc-b4bfcb32bcff | Dyural L Kit | Asclemed USA, Inc. | 20260108 |
| d944240d-2c19-46ba-ad4f-3fbee7b8629c | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | Amneal Pharmaceuticals LLC | 20251215 |
| 1084208f-3b86-4aef-8247-5b6ed6cd50c7 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | A-S Medication Solutions | 20251107 |
| 62f4339a-a971-414d-b407-ef030fe4f989 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | Sportpharm, Inc. dba Sportpharm | 20250807 |
| fb85b480-d0cd-2539-e053-6294a90a5083 | Multi-Specialty Kit | Advanced Rx Pharmacy of Tennessee, LLC | 20241231 |
| 01ca16de-ab2e-4e19-e063-6394a90a0510 | Dyural 40 Kit These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION.BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | Advanced Rx Pharmacy of Tennessee, LLC | 20241231 |
| cdd72141-10b6-48c6-85be-5b1294c8539c | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | Asclemed USA, Inc. | 20241005 |
| 151ae26c-bd4e-4582-b67a-7b5baf466953 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION.BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | Asclemed USA, Inc. | 20241005 |
| 112c196c-a143-4e4f-8b48-c9aa7b1119a8 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | Asclemed USA, Inc. | 20240701 |
| 1084208f-3b86-4aef-8247-5b6ed6cd50c7 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | A-S Medication Solutions | 20240603 |
| b10fa870-0457-41ca-b2f2-8eea3ae88486 | MethylPREDNISolone Acetate Injectable Suspension, USP | REMEDYREPACK INC. | 20220208 |
| b431147a-5dfa-4c4f-bab4-6e00ff4324e0 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | REMEDYREPACK INC. | 20211227 |
| 978b8416-2e88-4816-8a37-bb20b9af4b1d | MethylPREDNISolone Acetate Injectable Suspension, USP | Teva Parenteral Medicines, Inc. | 20210630 |
| 40e871a8-98ea-46bd-a593-ab800da186b4 | MethylPREDNISolone Acetate Injectable Suspension, USP | Northstar RxLLC | 20210630 |
| 9a3f33a6-a651-4ebc-e053-2995a90aadd7 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP 40mg/mL, 1mL VIAL | HF Acquisition Co LLC, DBA HealthFirst | 20200222 |
| 397cad9e-ab18-4271-8a17-9387c2358c49 | MethylPREDNISolone ACETATE Injectable Suspension USP | Proficient Rx LP | 20200201 |
| 28247e4a-0a18-0365-e054-00144ff88e88 | ReadySharp-P40 | Terrain Pharmaceuticals | 20161213 |
| 369e030c-1ea4-4104-885c-a60d6cedf072 | MethylPREDNISolone ACETATE Injectable Suspension USP | Physicians Total Care, Inc. | 20120829 |
| 6429d76a-1027-42c2-99a3-6aa41a47f3ad | National Council for Prescription Drug Programs | 20120724 | |
| 6dd13c01-39a1-436a-8af8-8ea5aae73547 | National Council for Prescription Drug Programs | 20120724 | |
| 82eeb304-a94b-412c-be82-081fb165c811 | National Council for Prescription Drug Programs | 20120724 | |
| dd60b1bb-4237-414e-98d9-ec80a9de0570 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D10AA | Corticosteroids, combinations for treatment of acne | ATC1-4 | methylprednisolone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | methylprednisolone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | methylprednisolone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | methylprednisolone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | D008775 | Methylprednisolone | CHEM | has_ingredient | methylprednisolone |
| MEDRT | D000077555 | Methylprednisolone Acetate | CHEM | has_ingredient | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 40 MG/ML (expressed as methylprednisolone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | QUANTITY | 1 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA210043 |
| CODES | ANDA | ANDA220556 |
| CODES | VUID | 4003432 |
| NAMES | Prescribable Synonym | methylPREDNISolone acetate 40 MG in 1 ML Injection |
| NAMES | Tallman Synonym | 1 ML methylPREDNISolone acetate 40 MG/ML Injection |
| NAMES | Tallman Synonym | methylPREDNISolone acetate 40 MG per 1 ML Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |